Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Vivian I. Franco"'
Autor:
Lisa M. Kopp, Richard B. Womer, Cindy L. Schwartz, David H. Ebb, Vivian I. Franco, David Hall, Donald A. Barkauskas, Mark D. Krailo, Holcombe E. Grier, Paul A. Meyers, Leonard H. Wexler, Neyssa M. Marina, Katherine A. Janeway, Richard Gorlick, Mark L. Bernstein, Steven E. Lipshultz, for the Children’s Oncology Group
Publikováno v:
Cardio-Oncology, Vol 5, Iss 1, Pp 1-12 (2019)
Abstract Background Dexrazoxane protects from lower-cumulative-dose doxorubicin cardiotoxicity, but the effect of dexrazoxane in children with sarcoma treated with higher-cumulative-dose doxorubicin is unknown. Methods We evaluated children with oste
Externí odkaz:
https://doaj.org/article/c1df26e926ca40859f1f7499883d65cd
Publikováno v:
Cardiology Research and Practice, Vol 2011 (2011)
Externí odkaz:
https://doaj.org/article/6fcf3451414b43f8a96f3f1d56660ade
Autor:
Cindy L. Schwartz, Richard Gorlick, David H. Ebb, Donald A. Barkauskas, Paul A. Meyers, Leonard H. Wexler, Lisa M. Kopp, Neyssa Marina, Mark Krailo, Mark L. Bernstein, Vivian I. Franco, Steven E. Lipshultz, David Hall, Holcombe E. Grier, Richard B. Womer, Katherine A. Janeway
Publikováno v:
Cardio-Oncology, Vol 5, Iss 1, Pp 1-12 (2019)
Cardio-oncology
Cardio-oncology
Background Dexrazoxane protects from lower-cumulative-dose doxorubicin cardiotoxicity, but the effect of dexrazoxane in children with sarcoma treated with higher-cumulative-dose doxorubicin is unknown. Methods We evaluated children with osteosarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3c4d3b7567f42d3460ef44f3d8b36f
http://link.springer.com/article/10.1186/s40959-019-0050-9
http://link.springer.com/article/10.1186/s40959-019-0050-9
Publikováno v:
British Journal of Clinical Pharmacology. 83:455-465
Linked Articles This article is part of a joint Themed section with the British Journal of Pharmacology on Cardiotoxicity. The rest of the Themed section will appear in a future issue of BJP and will be available at http://onlinelibrary.wiley.com/jou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3419db26764c4a88bf70f360ef500f4
https://doi.org/10.1111/bcp.13120
https://doi.org/10.1111/bcp.13120
Autor:
Kristen E. Stevenson, Lewis B. Silverman, Donna Neuberg, Lynn Anderson, Lynda M. Vrooman, Vivian I. Franco, Tracie L. Miller, Stephen E. Sallan, Daniel E. Libutti, Mariana Gerschenson, Steven E. Lipshultz
Publikováno v:
Cancer. 122:946-953
BACKGROUND Impaired cardiac function in doxorubicin-treated childhood cancer survivors is partly mediated by the disruption of mitochondrial energy production. Doxorubicin intercalates into mitochondrial DNA (mtDNA) and disrupts genes encoding for po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a61c4d9fab5dd47e289a34a7aef15ad
https://doi.org/10.1002/cncr.29872
https://doi.org/10.1002/cncr.29872
Autor:
Iki Adachi, Jyothsna Akam-Venkata, Christopher S. Almond, Jeffrey B. Anderson, Jean Ballweg, Neha Bansal, Christine Benhase, Daniel Bernstein, Elizabeth D. Blume, Luke J. Burchill, Michael Burch, Sarah Burki, Jonathan W. Byrnes, Antonio G. Cabrera, Bryan Cannon, Charles E. Canter, Anthony C. Chang, Steven D. Colan, Jennifer L. Conway, Weining David Xu, Ryan R. Davies, Susan W. Denfield, Anne I. Dipchand, Mary T. Donofrio, William J. Dreyer, David J. Driscoll, Lucas Eastaugh, Melanie D. Everitt, James C. Fang, Theresa J. Faulkner, Alejandro A. Floh, Vivian I. Franco, Charles D. Fraser, Mark K. Friedberg, Francis Fynn-Thompson, Kristen George, Matthew J. Gillespie, Andrew C. Glatz, David J. Goldberg, Stuart L. Goldstein, Samuel Hanke, Karen Hendricks, Ray Hershberger, Ziyad M. Hijazi, Timothy M. Hoffman, Ralf J. Holzer, Alexander Hussey, Julia H. Indik, Frank Ing, Dunbar Ivy, Robert D.B. Jacquiss, Edgar T. Jaeggi, Emily Jean-St.-Michel, Aamir Jeewa, John L. Jefferies, Jason Johnson, Jonathan N. Johnson, Ahmad Kaddourah, Paul F. Kantor, Jeffrey J. Kim, Steven J. Kindel, James K. Kirklin, Bernhard Kuhn, Jennifer Lail, Kory J. Lavine, Kimberly Y. Lin, Steven E. Lipshultz, Angela Lorts, Kevin O. Maher, Douglas L. Mann, Frank I. Marcus, Renee Margossian, Bradley S. Marino, Jacob Mathew, Tim Maul, Luisa Mestroni, Shelley D. Miyamoto, Ana Morales, David L.S. Morales, Maryam Y. Naim, Stephanie J. Nakano, Deipanjan Nandi, David P. Nelson, Michael L. O’Byrne, Matthew J. O’Connor, Alexander R. Opotowsky, Francis D. Pagani, Elfriede Pahl, Daniel J. Penny, Jack F. Price, Ilaria Puggia, Chitra Ravishankar, Andrew N. Redington, Jonathan J. Rome, David N. Rosenthal, Joseph W. Rossano, Heather J. Ross, Robert D. Ross, Teisha J. Rowland, Thomas D. Ryan, Kurt R. Schumacher, Matthew C. Schwartz, Steven M. Schwartz, Robert E. Shaddy, Maully J. Shah, Jacob Simmonds, Kathleen E. Simpson, Gianfranco Sinagra, Juli Sublett, Patrick Sullivan, Hussam Suradi, David L. Sutcliffe, Cheryl Takao, Michael Taylor, Timothy Thiruchelvam, Philip T. Thrush, Jeffrey A. Towbin, James S. Tweddell, Simon Urschel, Christina J. VanderPluym, Philip Wackel, Jack Wallen, Peter Wearden, Robert G. Weintraub, Scott L. Weiss, Shawn West, James T. Willerson, Ivan Wilmot, Judith Wilson, Mahsun Yuerek, Matthew Zinn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::725e7616e0fa56ab83d07e23e97cbc7b
https://doi.org/10.1016/b978-0-12-802393-8.01002-4
https://doi.org/10.1016/b978-0-12-802393-8.01002-4
In cancer treatment, the pervasive late effects of radiation and chemotherapy limit their utility, especially in children, in whom treatment often leads to lifelong morbidity and excess mortality. Advances in understanding the molecular pathways rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f38e94a0fa541cceac4d7b6c3bd37b82
https://doi.org/10.1016/b978-0-12-801238-3.95641-1
https://doi.org/10.1016/b978-0-12-801238-3.95641-1
Autor:
Davide Tamburro, Stephen E. Sallan, Tracie L. Miller, Mark M. Ross, Steven E. Lipshultz, Eugene H. Herman, Alessandra Luchini, Weidong Zhou, Rebecca E. Scully, Vivian I. Franco, Lance A. Liotta, Emanuel F. Petricoin
Publikováno v:
Progress in Pediatric Cardiology. 39:85-91
Cardiotoxicity related to doxorubicin chemotherapy is a major late effect in childhood cancer survivors. Serum cardiac troponin concentrations (cTnT) can be elevated during doxorubicin therapy but the cellular associations with this myocardial injury
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9436e23a3bc9706b5b07a082d9b8b60
https://doi.org/10.1016/j.ppedcard.2015.10.005
https://doi.org/10.1016/j.ppedcard.2015.10.005
Publikováno v:
Annual Review of Medicine. 66:161-176
Treatment advances have increased survival in children with cancer, but subclinical, progressive, irreversible, and sometimes fatal treatment-related cardiovascular effects may appear years later. Cardio-oncologists have identified promising preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5532e7c82dcaf1b9ede59e831b8427d8
https://doi.org/10.1146/annurev-med-070213-054849
https://doi.org/10.1146/annurev-med-070213-054849
Within the first 30 years after cancer diagnosis, survivors of childhood cancers have an estimated 75% cumulative incidence of treatment-related chronic health problems. In the United States, where 1 in 680 people between 20 and 50 years old are surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe4e59bff896e075559fac4df75ce6e8
https://doi.org/10.1016/b978-0-12-803547-4.00011-2
https://doi.org/10.1016/b978-0-12-803547-4.00011-2